Skip to main content
TEM
NASDAQ Technology

Tempus AI Reports Strong Q1 Revenue Growth, Improved EBITDA, and Raises Full-Year Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$51.2
Mkt Cap
$9.7B
52W Low
$41.73
52W High
$104.32
52W Position info
23% above low
Off High info
51% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

TEM sits 23% above its 52-week low of $41.73.

Summary

Tempus AI reported strong first-quarter 2026 financial results, including a 36.1% year-over-year revenue increase and a significant improvement in Adjusted EBITDA, leading to raised full-year revenue guidance.


Key Events · Earnings and Guidance · TEM

  • Strong Q1 Revenue Growth

    Revenue increased 36.1% year-over-year to $348.1 million, driven by 34.7% growth in Diagnostics revenue and 40.5% growth in Data and Applications revenue.

  • Significant Adjusted EBITDA Improvement

    Adjusted EBITDA improved substantially from a loss of $16.2 million in Q1 2025 to a loss of $2.8 million in Q1 2026, indicating progress towards profitability.

  • Raised Full-Year Revenue Guidance

    The company increased its full-year 2026 revenue guidance to a range of $1.59 billion to $1.60 billion, representing approximately 25% annual growth.

  • Key Strategic Collaborations and Milestones

    Tempus AI announced new multi-year strategic collaborations with Merck, Gilead, Northwestern Medicine, and NYU Langone Health, alongside positive study results for its AI-driven diagnostic platforms.


Analysis · TEM · Technology

Tempus AI's first-quarter results demonstrate robust operational performance, with significant revenue growth and a substantial improvement in Adjusted EBITDA, nearing profitability. The company's decision to raise its full-year revenue guidance signals confidence in continued momentum. This positive financial update provides a strong counterpoint to recent insider selling activity, suggesting that the company's underlying business fundamentals are strengthening. Investors should monitor the continued execution of strategic collaborations and the path to sustained profitability.

At the time of this filing, TEM was trading at $51.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $9.7B. The 52-week trading range was $41.73 to $104.32. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TEM - Latest Insights

TEM
Aug 04, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $46.50
Real-time Price: $46.32 info
Change: -$0.180 (-0.39%) info
Market Cap: $8.358B info
TEM
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $44.05
Real-time Price: $46.32 info
Change: +$2.27 (+5%) info
Market Cap: $8.358B info
TEM
Jul 30, 2026, 5:06 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $43.63
Real-time Price: $46.32 info
Change: +$2.69 (+6%) info
Market Cap: $8.358B info
TEM
Jul 30, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $43.25
Real-time Price: $46.32 info
Change: +$3.07 (+7%) info
Market Cap: $8.358B info
TEM
Jul 30, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $44.29
Real-time Price: $46.32 info
Change: +$2.03 (+5%) info
Market Cap: $8.358B info